Your browser doesn't support javascript.
loading
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination.
Lövgren, Tanja; Wolodarski, Maria; Wickström, Stina; Edbäck, Ulrika; Wallin, Mette; Martell, Eva; Markland, Katrin; Blomberg, Pontus; Nyström, Maria; Lundqvist, Andreas; Jacobsson, Hans; Ullenhag, Gustav; Ljungman, Per; Hansson, Johan; Masucci, Giuseppe; Tell, Roger; Poschke, Isabel; Adamson, Lars; Mattsson, Jonas; Kiessling, Rolf.
  • Lövgren T; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Wolodarski M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Wickström S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Edbäck U; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Wallin M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Martell E; Center for Clinical Cancer Studies, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Markland K; Center for Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Blomberg P; Vecura, Karolinska Cell Therapy Center, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Nyström M; Vecura, Karolinska Cell Therapy Center, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Lundqvist A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Jacobsson H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Ullenhag G; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Ljungman P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Hansson J; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
  • Masucci G; Center for Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Tell R; Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Poschke I; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Adamson L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Mattsson J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Kiessling R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Oncoimmunology ; 9(1): 1792058, 2020 07 11.
Article en En | MEDLINE | ID: mdl-32923156
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article